Emcure Pharmaceuticals and Sanofi India have entered into a distribution agreement to promote Sanofi's oral anti-diabetic products, Amaryl and Cetapin, across India.

Thermo Fisher said on Wednesday it will buy Sanofi's manufacturing site in Ridgefield, New Jersey, to produce critical ...

The partnership will see Emcure leverage its extensive network to distribute and promote well-established Sanofi brands such as Amaryl (glimepiride) and Cetapin (metformin).

Emcure Pharmaceuticals and Sanofi India have entered in a partnership to distribute and promote Sanofi’s oral anti-diabetic ...

Under the expanded partnership, Thermo Fisher will acquire Sanofi's sterile fill-finish and packaging facility in Ridgefield, N.J. The science-services and instruments provider said Wednesday that it ...

Emcure Pharmaceuticals and Sanofi India have announced a distribution agreement. Emcure will promote Sanofi India's oral anti-diabetic products like Amaryl and Cetapin. Sanofi India will continue to ...

Thermo Fisher Scientific Inc. has expanded its strategic partnership with Sanofi to enable additional U.S. drug product manufacturing.

Emcure Pharmaceuticals and Sanofi India announce exclusive distribution agreement for Sanofi's oral anti-diabetic products in ...

The Board of Directors, acting on the recommendation of the Nomination and Remuneration Committee, has approved the appointment of Mr. Rachid Ayari (DIN: 10408699) as the Interim Managing Director of ...

To distribute and promote Emcure's oral anti-diabetic (OAD) products in India Emcure Pharmaceuticals (Emcure) and Sanofi India (SIL) today entered into an exclusive distribution and promotion ...

Emcure Pharmaceuticals and Sanofi India have partnered in an exclusive distribution and promotion agreement for Sanofi's oral ...

Sanofi has been granted a speedy review from the FDA for a gene therapy for geographic atrophy (GA), a complication of age-related macular degeneration (AMD), as it prepares to test it in a clinical ...